The group's principle activities include developing and marketing molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The group also provides PNA FISH(TM) and EVIGENE(TM) test that provides rapid identification results for bacteria and yeast to support appropriate antibiotic therapy and improve overall patient care. The group operates from United States and Europe.
